Aarti Industries Limited AARTIIND.NS Stock
Aarti Industries Limited Price Chart
Aarti Industries Limited AARTIIND.NS Financial and Trading Overview
Aarti Industries Limited stock price | 724.45 INR |
Previous Close | 520.4 INR |
Open | 521.5 INR |
Bid | 523.05 INR x 0 |
Ask | 523 INR x 0 |
Day's Range | 521 - 523.95 INR |
52 Week Range | 482.4 - 924.4 INR |
Volume | 59.57K INR |
Avg. Volume | 961.83K INR |
Market Cap | 189.59B INR |
Beta (5Y Monthly) | 0.583561 |
PE Ratio (TTM) | 34.797073 |
EPS (TTM) | 11.94 INR |
Forward Dividend & Yield | 2.5 (0.47%) |
Ex-Dividend Date | February 15, 2023 |
1y Target Est | N/A |
AARTIIND.NS Valuation Measures
Enterprise Value | 215.44B INR |
Trailing P/E | 34.797073 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.8643236 |
Price/Book (mrq) | 3.8631144 |
Enterprise Value/Revenue | 3.255 |
Enterprise Value/EBITDA | 19.783 |
Trading Information
Aarti Industries Limited Stock Price History
Beta (5Y Monthly) | 0.583561 |
52-Week Change | -24.44% |
S&P500 52-Week Change | 20.43% |
52 Week High | 924.4 INR |
52 Week Low | 482.4 INR |
50-Day Moving Average | 528.29 INR |
200-Day Moving Average | 611.27 INR |
AARTIIND.NS Share Statistics
Avg. Volume (3 month) | 961.83K INR |
Avg. Daily Volume (10-Days) | 912.95K INR |
Shares Outstanding | 362.5M |
Float | 199.19M |
Short Ratio | N/A |
% Held by Insiders | 44.43% |
% Held by Institutions | 22.42% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.5 |
Trailing Annual Dividend Yield | 0.48% |
5 Year Average Dividend Yield | 35.00% |
Payout Ratio | 0.16620001 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 8.23% |
Operating Margin (ttm) | 11.76% |
Gross Margin | 41.95% |
EBITDA Margin | 16.45% |
Management Effectiveness
Return on Assets (ttm) | 5.33% |
Return on Equity (ttm) | 10.05% |
Income Statement
Revenue (ttm) | 66.19B INR |
Revenue Per Share (ttm) | 182.66 INR |
Quarterly Revenue Growth (yoy) | -5.70% |
Gross Profit (ttm) | 27.77B INR |
EBITDA | 10.89B INR |
Net Income Avi to Common (ttm) | 5.45B INR |
Diluted EPS (ttm) | 15.03 |
Quarterly Earnings Growth (yoy) | -23.10% |
Balance Sheet
Total Cash (mrq) | 2B INR |
Total Cash Per Share (mrq) | 5.5 INR |
Total Debt (mrq) | 29.07B INR |
Total Debt/Equity (mrq) | 59.07 INR |
Current Ratio (mrq) | 0.883 |
Book Value Per Share (mrq) | 135.383 |
Cash Flow Statement
Operating Cash Flow (ttm) | 13.1B INR |
Levered Free Cash Flow (ttm) | -195987504 INR |
Profile of Aarti Industries Limited
Country | India |
State | N/A |
City | Mumbai |
Address | 71, Udyog Kshetra |
ZIP | 400080 |
Phone | 91 22 6797 6666 |
Website | https://www.aarti-industries.com |
Industry | Specialty Chemicals |
Sector(s) | Basic Materials |
Full Time Employees | N/A |
Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. The company offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in various processes, such as chlorination, nitration, hydrogenation, ammonolysis, halex, dinitro chlorination, alkylation, hydrolysis, methoxylation, esterification, diazotization, sulphonation, condensation, n-alkylation, and oxidation. It also provides active pharmaceutical ingredientsfor use in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, the company offers intermediates comprising bazedoxifene, canagliflozin, tofacitinib, idelalisib, rotigotine, lacosamide, apixaban, bosutinib, ibrutinib, teneligliptin, lumacaftor, empagliflozin, osimertinib, ivabradine, moxifloxacin, montelukast, ramipril1, quinapril, perindopril tert- butylamine, ranolazine, fluoxetine, duloxetine, venlafaxine hydrochloride, quetiapine fumarate1, abemaciclib, acalabrutinib, apalutamide, eluxadoline, enzalutamide, ertugliflozin, neratinib, palbociclib/ ribociclib, venetoclax, and afatinib; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract development and manufacturing services. It also exports its products to approximately 60 countries in the United States, Europe, China, Japan, and internationally. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Q&A For Aarti Industries Limited Stock
What is a current AARTIIND.NS stock price?
Aarti Industries Limited AARTIIND.NS stock price today per share is 724.45 INR.
How to purchase Aarti Industries Limited stock?
You can buy AARTIIND.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aarti Industries Limited?
The stock symbol or ticker of Aarti Industries Limited is AARTIIND.NS.
Which industry does the Aarti Industries Limited company belong to?
The Aarti Industries Limited industry is Specialty Chemicals.
How many shares does Aarti Industries Limited have in circulation?
The max supply of Aarti Industries Limited shares is 362.65M.
What is Aarti Industries Limited Price to Earnings Ratio (PE Ratio)?
Aarti Industries Limited PE Ratio is 60.67420600 now.
What was Aarti Industries Limited earnings per share over the trailing 12 months (TTM)?
Aarti Industries Limited EPS is 11.94 INR over the trailing 12 months.
Which sector does the Aarti Industries Limited company belong to?
The Aarti Industries Limited sector is Basic Materials.